Our Featured Knowledge
Blog Post
.webp)
Does Annex 22 Close the Door on GenAI in Validation?
Explore the implications of draft EU GMP Annex 22 on generative AI in validation, focusing on risk management and responsible governance in GxP environments.
Read
Webinar
Revolutionizing CMC in Drug Development: How to Reduce Errors and Delays in Quality by Design
Power up your QbD journey with integrated tools that enhance collaboration, data integrity, and risk management.
Watch
Industry Insight
From AI Assistance to Governed Execution: Rethinking Control in CQV
Explore how governed AI can reduce execution variability in CQV, support right-first-time performance, and extend assurance while keeping human judgment and accountability in control.
Read